21 May 2009
Primary prophylaxis of HPV infection in surgical theatre staff – is it needed?
M Woźniak, M Leśniewska, M Kotomska, A Nowak, A Ksit-Bąbel, E Nosarzewska, P FiedorAnn Transplant 2009; 14(1): 86-86 :: ID: 880516
Abstract
Chronic HPV infection is thought to be the main causative factor in the development of cervical cancer. The predominant mode of transmission is a sexual intercourse. Factors increasing the risk of HPV infection include an early sexual initiation, large number of partners, unprotected intercourse. HPV infection prevention is now considered to be a mode of primary prophylaxis of cervical cancer A significant role in prevention and eradication of HPV infection is seen in prophylactic vaccination which fully prevents HPV type 16, 18 infections considered responsible for 70% cases of cervical cancer and HPV
type 6, 11 responsible for genital warts. Vaccination and the adherence to the rules of "safe sex" may drastically reduce the incidence of cervical cancer and the spread of infection, also among the personnel of surgical theatres who are exposed to infected body parts during the course of their work. Direct contact of nursing staff with patients, especially chronically immunosuppressed transplant recipients exposes those team members to an infection risk. Preventive vaccinations currently protect medical professionals from HBV infections by stimulating the production of protective antibody levels. It is postulated that anti-HPV vaccination should be included in the protective vaccination schedule of medical professionals at a special risk of exposure.
Keywords: Primary prophylaxis
In Press
Original article
Fundamental Strategies and Technical Perspectives in Bile Duct Anastomosis for Living Donor Liver Transplan...Ann Transplant In Press; DOI: 10.12659/AOT.953761
Clinical Research
Retrospective Study of Implementation and Outcomes of a Non-Cryopreserved Autologous Hematopoietic Stem Cel...Ann Transplant In Press; DOI: 10.12659/AOT.954230
Clinical Research
Prognostic Prediction in Living Donor Liver Transplantation Recipients With Complete Pathological Response ...Ann Transplant In Press; DOI: 10.12659/AOT.954574
Most Viewed Current Articles
24 Aug 2021 : Review article 21,978
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
29 Dec 2021 : Original article 18,247
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588
22 Nov 2022 : Original article 16,856
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
05 Apr 2022 : Original article 16,762
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604






